1,2-bis(2,5-dimethylphenyl)ethene

ID: ALA3134409

Chembl Id: CHEMBL3134409

PubChem CID: 13354153

Max Phase: Preclinical

Molecular Formula: C18H20

Molecular Weight: 236.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(C)c(/C=C/c2cc(C)ccc2C)c1

Standard InChI:  InChI=1S/C18H20/c1-13-5-7-15(3)17(11-13)9-10-18-12-14(2)6-8-16(18)4/h5-12H,1-4H3/b10-9+

Standard InChI Key:  WELLRJIWOYUIFH-MDZDMXLPSA-N

Associated Targets(Human)

TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
supX DNA topoisomerase (69 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 236.36Molecular Weight (Monoisotopic): 236.1565AlogP: 5.09#Rotatable Bonds: 2
Polar Surface Area: 0.00Molecular Species: HBA: HBD:
#RO5 Violations: 1HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.37CX LogD: 6.37
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.64Np Likeness Score: -0.35

References

1. Lin H, Annamalai T, Bansod P, Tse-Dinh YC, Sun D..  (2013)  Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors.,  (12): [PMID:24363888] [10.1039/c3md00238a]

Source